1700040I university of texas medical branch; to A7 VB--17 task order funding; biod can 8470038 $417,060

Ended Awarded Last action

Contract number
HHSN27200007
Awardee
Awarding agency
Obligated
$615,630

Award facts

Opportunity
  • NIHAI2016059 Solicitation number
Contract value 81% obligated
  • $615,629.77 Current, with exercised options
  • $762,903.77 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Galveston, TX 77555, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00005 -$129,191
Exercise an Option P00004 · The purpose of this modification is to: (1) exercise the second travel option in the amount of $4,524 for the catg meeting to be held on april 30 to may 01,… $4,524
Exercise an Option P00003 · The purpose of this modification is to exercise quantity option 2 in the amount of $162,502. $162,502
Exercise an Option P00002 · The purpose of this modification is to exercise quantity option 3 in the amount of $156,211. $156,211
Exercise an Option 1 · The purpose of this modification is to exercise the travel option in the amount of $4,524 for the catg meeting to be held on april 24-25, 2018 in rockville, MD. $4,524
Original award $417,060

About this award

This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a potential value of $762,903.77. The contract is not set aside. Under this vehicle, UTMB provides preclinical research services to support the development of treatments for infectious diseases such as HIV/AIDS, hepatitis, and tuberculosis. UTMB also holds other federal contracts and grants with agencies like the NIH and CDC to conduct medical research, public health initiatives, and training related to high consequence pathogens.

Quick answers

Who was awarded contract HHSN27200007?

HHSN27200007 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 27, 2017.

How much is contract HHSN27200007 worth?

The government has obligated $615,630 on HHSN27200007. Its potential value, with all options, is $762,904.

Is contract HHSN27200007 an order under another contract?

Yes. HHSN27200007 is a delivery order under HHSN272201700040I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.

Was contract HHSN27200007 competed?

The extent of competition for HHSN27200007 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award